Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TSHATaysha Gene Therapies, Inc.

Nasdaq · CIK 0001806310
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts247

Identity from submissions API

NameTaysha Gene Therapies, Inc.
CIK0001806310
TickersTSHA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN843199512
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(214) 612-0000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3000 PEGASUS PARK DRIVE
SUITE 1430
DALLAS
TX
75247
TX
Mailing address
3000 PEGASUS PARK DRIVE
SUITE 1430
DALLAS
TX
75247
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

404 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000295 005-91724 261563037 34 15549
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-456974 001-39536 261543270 34 230277 1 1
2026-11-12 10-Q 10-Q 0001193125-26-456949 001-39536 261543211 34 15958269 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000928 005-91724 261283107 34 15604
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000895421-26-000269 005-91724 261275141 34 12043
2026-08-11 10-Q 10-Q 0001193125-26-344610 001-39536 261263209 34 15375549 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-344594 001-39536 261263145 34 242304 1 1
2026-07-10 4 xslF345X06/form4-07102026_100732.xml 0001665124-26-000013 5502
2026-07-10 144 xsl144X01/primary_doc.xml 0001974158-26-000076 001-39536 261168963 33 5831
2026-06-25 8-K 8-K 1.01,8.01,9.01 0001193125-26-282855 001-39536 261122251 34 541878 1 1
2026-06-25 424B5 424B5 0001193125-26-282846 333-291244 261122225 33 2836404 1 1
2026-06-24 424B5 424B5 0001193125-26-281288 333-291244 261116900 33 2692028
2026-06-22 8-K 8-K 7.01,8.01,9.01 0001193125-26-276738 001-39536 261105007 34 4484848 1 1
2026-06-02 4 xslF345X06/form4-06022026_040616.xml 0001709418-26-000002 8481
2026-06-02 4 xslF345X06/form4-06022026_040614.xml 0001238120-26-000008 7553
2026-06-02 4 xslF345X06/form4-06022026_040612.xml 0001891712-26-000002 7441
2026-06-02 4 xslF345X06/form4-06022026_040610.xml 0001777421-26-000005 7470
2026-06-02 8-K 8-K 5.07 0001193125-26-253478 001-39536 261055898 34 152724 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-002553 005-91724 26989663 34 10940
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000122 005-91724 26982614 34 10693
2026-05-06 10-Q 10-Q 0001193125-26-207666 001-39536 26945944 34 9737718 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001193125-26-207633 001-39536 26945910 34 224613 1 1
2026-04-22 ARS ARS 0001193125-26-168538 001-39536 26881331 34 12068726
2026-04-22 DEFA14A DEFA14A 0001193125-26-168533 001-39536 26881327 34 979597
2026-04-22 DEF 14A DEF 14A 0001193125-26-168525 001-39536 26881323 34 2834696 1 1
2026-04-13 4 xslF345X06/form4-04132026_080454.xml 0001665124-26-000011 9450
2026-04-10 144 xsl144X01/primary_doc.xml 0001974158-26-000040 001-39536 26854984 33 6358
2026-03-19 10-K 10-K 0001193125-26-115202 001-39536 26772532 34 19866549 1 1
2026-03-19 8-K 8-K 2.02,9.01 0001193125-26-115177 001-39536 26772480 34 225875 1 1
2026-02-27 144 xsl144X01/primary_doc.xml 0002086827-26-000008 001-39536 26699733 33 7102
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001081 005-91724 26641058 34 14899
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493215-26-000050 005-91724 26636800 34 10745
2026-02-06 4 xslF345X05/form4-02062026_040223.xml 0001793412-26-000012 4900
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000536 005-91724 26602068 34 11485
2026-02-04 144 xsl144X01/primary_doc.xml 0001977343-26-000005 001-39536 26599776 33 6453
2026-02-04 144 xsl144X01/primary_doc.xml 0001979666-26-000006 001-39536 26599773 33 6454
2026-02-04 144 xsl144X01/primary_doc.xml 0001979693-26-000007 001-39536 26599767 33 6434
2026-02-04 144 xsl144X01/primary_doc.xml 0002086827-26-000006 001-39536 26599758 33 6336
2026-02-04 144 xsl144X01/primary_doc.xml 0001793412-26-000010 001-39536 26599751 33 6253
2026-01-27 4 xslF345X05/form4-01272026_040105.xml 0001665124-26-000008 7232
2026-01-27 4 xslF345X05/form4-01272026_040103.xml 0001569926-26-000008 8184
2026-01-27 4 xslF345X05/form4-01272026_040101.xml 0001793412-26-000008 7161
2026-01-23 144 xsl144X01/primary_doc.xml 0001569926-26-000006 001-39536 26558234 33 4861
2026-01-23 144 xsl144X01/primary_doc.xml 0001665124-26-000006 001-39536 26558230 33 6260
2026-01-23 144 xsl144X01/primary_doc.xml 0002086827-26-000004 001-39536 26558228 33 4809
2026-01-23 144 xsl144X01/primary_doc.xml 0001979666-26-000004 001-39536 26558227 33 4931
2026-01-23 144 xsl144X01/primary_doc.xml 0001977343-26-000003 001-39536 26558225 33 4935
2026-01-23 144 xsl144X01/primary_doc.xml 0001979693-26-000005 001-39536 26558220 33 4915
2026-01-23 144 xsl144X01/primary_doc.xml 0001793412-26-000006 001-39536 26558218 33 4740
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000794 005-91724 26545984 34 10962
2026-01-14 4 xslF345X05/form4-01142026_040105.xml 0001793412-26-000002 7394
2026-01-14 4 xslF345X05/form4-01142026_040103.xml 0001569926-26-000002 8399
2026-01-14 4 xslF345X05/form4-01142026_040101.xml 0001665124-26-000002 17443
2026-01-12 144 xsl144X01/primary_doc.xml 0001974158-26-000011 001-39536 26526929 33 6483
2026-01-06 S-8 S-8 0001193125-26-004622 333-292589 26512226 33 241158 1 1
2025-12-01 4 xslF345X05/form4-12022025_011240.xml 0001665124-25-000003 18340
2025-11-28 144 xsl144X01/primary_doc.xml 0001974158-25-000077 001-39536 251534388 33 5504
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-016718 005-91724 251487626 34 10941
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001231919-25-000491 005-91724 251486615 34 15365
2025-11-04 S-3ASR S-3ASR 0001193125-25-263634 333-291244 251446592 33 1472909 1 1
2025-11-04 8-K 8-K 1.01,2.02,9.01 0001193125-25-263543 001-39536 251446430 34 329188 1 1
2025-11-04 10-Q 10-Q 0001193125-25-263506 001-39536 251446346 34 16807875 1 1
2025-10-16 8-K 8-K 8.01,9.01 0001193125-25-241415 001-39536 251397729 34 165427 1 1
2025-10-09 8-K 8-K 8.01,9.01 0001193125-25-235212 001-39536 251383651 34 170641 1 1
2025-10-02 8-K 8-K 8.01,9.01 0001193125-25-227505 001-39536 251367069 34 169980 1 1
2025-09-22 144 xsl144X01/primary_doc.xml 0002086827-25-000002 001-39536 251331303 33 4796
2025-09-12 4 xslF345X05/form4-09122025_040917.xml 0001415889-25-024369 9250
2025-09-10 144 xsl144X01/primary_doc.xml 0001974158-25-000058 001-39536 251306173 33 6388
2025-08-22 4 xslF345X05/form4-08222025_040806.xml 0001415889-25-022750 5414
2025-08-22 4 xslF345X05/form4-08222025_040804.xml 0001415889-25-022749 5361
2025-08-21 144 xsl144X01/primary_doc.xml 0001415889-25-022689 001-39536 251242069 33 4728
2025-08-21 144 xsl144X01/primary_doc.xml 0001415889-25-022687 001-39536 251242068 33 4923
2025-08-21 144 xsl144X01/primary_doc.xml 0001415889-25-022685 001-39536 251242066 33 4873
2025-08-21 144 xsl144X01/primary_doc.xml 0001415889-25-022683 001-39536 251242060 33 4903
2025-08-21 144 xsl144X01/primary_doc.xml 0001415889-25-022681 001-39536 251242058 33 4920
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-022033 005-91724 251221574 34 15551
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-021712 005-91724 251214494 34 10941
2025-08-12 10-Q 10-Q 0000950170-25-107010 001-39536 251205003 34 14033270 1 1
2025-08-12 8-K 8-K 2.02,9.01 0001193125-25-178504 001-39536 251204141 34 244573 1 1
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000463 005-91724 251188917 34 12022
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002098 005-91724 251188460 34 11101
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002549 005-91724 251128502 34 10895
2025-07-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000769993-25-000401 005-91724 251104496 34 15746
2025-06-04 4 xslF345X05/form4-06042025_040609.xml 0001415889-25-015574 8348
2025-06-04 4 xslF345X05/form4-06042025_040607.xml 0001415889-25-015573 7420
2025-06-04 4 xslF345X05/form4-06042025_040604.xml 0001415889-25-015572 7308
2025-06-04 4 xslF345X05/form4-06042025_040601.xml 0001415889-25-015571 7337
2025-06-03 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-015487 005-91724 251021799 34 20556
2025-06-03 4 xslF345X05/form4-06042025_010624.xml 0001415889-25-015480 9486
2025-06-03 8-K 8-K 5.03,5.07,9.01 0001193125-25-133745 001-39536 251017133 34 164287 1 1
2025-05-29 8-K 8-K 1.01,8.01,9.01 0001193125-25-130709 001-39536 251004092 34 1688455 1 1
2025-05-29 424B5 424B5 0001193125-25-130693 333-283801 251003984 33 2699602
2025-05-29 8-K/A 8-K/A 7.01,8.01,9.01 0001193125-25-129849 001-39536 25997532 34 14128268 1 1
2025-05-28 424B5 424B5 0001193125-25-129569 333-283801 25996230 33 2701880
2025-05-28 8-K 8-K 7.01,8.01,9.01 0001193125-25-129494 001-39536 25995553 34 4368482 1 1
2025-05-15 10-Q 10-Q 0000950170-25-072036 001-39536 25948976 34 10197823 1 1
2025-05-15 8-K 8-K 2.02,9.01 0001193125-25-120329 001-39536 25948839 34 228396 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072014 005-91724 25948801 34 11026
2025-05-09 DEFR14A DEFR14A 0001193125-25-116882 001-39536 25930383 34 239336 1 1
2025-04-21 ARS ARS 0001193125-25-087223 001-39536 25853164 34 3805114
2025-04-21 DEFA14A DEFA14A 0001193125-25-087216 001-39536 25853089 34 317270
2025-04-21 DEF 14A DEF 14A 0001193125-25-087214 001-39536 25853059 34 1526932 1 1
2025-04-10 4/A xslF345X05/form4a-04102025_040408.xml 0001415889-25-010539 5813
2025-04-10 PRE 14A PRE 14A 0001193125-25-077943 001-39536 25828314 34 1534903 1 1
2025-03-13 4 xslF345X05/form4-03132025_040301.xml 0001415889-25-007997 4903
2025-02-26 10-K 10-K 0000950170-25-027348 001-39536 25666309 34 22251205 1 1
2025-02-26 8-K 8-K 2.02,9.01 0001193125-25-035882 001-39536 25666238 34 228262 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020476 005-91724 25623657 34 10872
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000808 005-91724 25612444 34 11626
2025-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-002035 005-91724 25594795 34 10767
2025-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000244 005-91724 25591381 34 11918
2025-01-07 S-8 S-8 0001193125-25-002868 333-284167 25515279 33 97248
2025-01-03 4 xslF345X05/form4-01032025_100137.xml 0001415889-25-000599 8678
2025-01-03 4 xslF345X05/form4-01032025_100136.xml 0001415889-25-000597 7727
2025-01-03 4 xslF345X05/form4-01032025_100118.xml 0001415889-25-000595 7656
2024-12-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-24-003902 333-283801 241569593 33 1796
2024-12-20 CORRESP filename1.htm 0001193125-24-282474 8023
2024-12-19 CORRESP filename1.htm 0001193125-24-282002 7976
2024-12-18 UPLOAD filename1.pdf 0000000000-24-013975 333-283801 40102
2024-12-13 S-3 S-3 0001193125-24-278466 333-283801 241548372 33 1378346
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119336 005-91724 241464793 34 157060
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119297 005-91724 241464736 34 88744
2024-11-14 SC 13G TAYSHA GENE THERAPIES, INC. 0000902664-24-006533 005-91724 241457867 34 64972
2024-11-13 10-Q 10-Q 0000950170-24-126416 001-39536 241455064 34 12512025 1 1
2024-11-13 8-K 8-K 2.02,9.01 0001193125-24-257205 001-39536 241454265 34 255833 1 1
2024-11-12 SC 13G/A filing.txt 0000315066-24-002879 005-91724 241444994 34 8261
2024-11-08 SC 13G us8776191061_110824.txt 0002012383-24-003575 005-91724 241439701 34 13768
2024-10-22 SC 13G us8776191061_102224.txt 0002012383-24-001567 005-91724 241387279 34 13754
2024-08-12 10-Q 10-Q 0000950170-24-095082 001-39536 241195005 34 12210992 1 1
2024-08-12 8-K 8-K 2.02,9.01 0001193125-24-198392 001-39536 241194797 34 248904 1 1
2024-07-05 144 xsl144X01/primary_doc.xml 0001231919-24-000053 001-39536 241103166 33 4721
2024-07-05 144 xsl144X01/primary_doc.xml 0001231919-24-000052 001-39536 241103165 33 4691
2024-07-05 144 xsl144X01/primary_doc.xml 0001231919-24-000051 001-39536 241103163 33 4698
2024-07-01 4 xslF345X05/form4-07012024_080703.xml 0001415889-24-018515 8700
2024-06-26 8-K 8-K 1.01,8.01,9.01 0001193125-24-169191 001-39536 241074510 34 614236 1 1
2024-06-26 424B5 424B5 0001193125-24-169188 333-260069 241074479 33 1940474
2024-06-26 8-K 8-K 2.02,8.01,9.01 0001193125-24-168479 001-39536 241070562 34 1402676 1 1
2024-06-26 424B5 424B5 0001193125-24-168470 333-260069 241070555 33 1941652
2024-06-18 8-K 8-K 7.01,9.01 0001193125-24-163050 001-39536 241050199 34 4464754 1 1
2024-05-31 4 xslF345X05/form4-05312024_040510.xml 0001415889-24-015041 8351
2024-05-31 4 xslF345X05/form4-05312024_040508.xml 0001415889-24-015040 7310
2024-05-31 4 xslF345X05/form4-05312024_040505.xml 0001415889-24-015039 7423
2024-05-31 4 xslF345X05/form4-05312024_040501.xml 0001415889-24-015038 7339
2024-05-30 8-K 8-K 5.07 0001193125-24-150323 001-39536 241005090 34 154401 1 1
2024-05-14 8-K 8-K 2.02,9.01 0001193125-24-138253 001-39536 24944625 34 234177 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059555 001-39536 24944479 34 9483239 1 1
2024-04-18 DEFA14A DEFA14A 0001193125-24-100817 001-39536 24854564 34 592452
2024-04-18 ARS ARS 0001193125-24-100808 001-39536 24854529 34 2128213
2024-04-18 DEF 14A DEF 14A 0001193125-24-100792 001-39536 24854453 34 433009
2024-03-19 S-8 S-8 0001193125-24-071452 333-278070 24764672 33 81611
2024-03-19 8-K 8-K 2.02,9.01 0001193125-24-071321 001-39536 24763466 34 254666 1 1
2024-03-19 10-K 10-K 0000950170-24-033484 001-39536 24763415 34 12845308 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024220 005-91724 24641684 34 156754
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024005 005-91724 24640149 34 92636
2024-02-14 SC 13G TAYSHA GENE THERAPIES, INC. 0000902664-24-001544 005-91724 24632231 34 66220
2024-02-09 SC 13G/A SC 13G/A 0001193125-24-030082 005-91724 24615396 34 57817
2024-02-09 SC 13G/A filing.txt 0000315066-24-001456 005-91724 24612049 34 8290
2024-02-06 4 xslF345X05/form4-02062024_090255.xml 0001415889-24-002809 4886
2024-01-10 8-K 8-K 7.01,9.01 0001193125-24-005637 001-39536 24524898 34 170045 1 1
2024-01-04 4 FORM 4 SUBMISSION 0001209191-24-000811 7533
2024-01-04 4 FORM 4 SUBMISSION 0001209191-24-000809 7605
2024-01-04 4 FORM 4 SUBMISSION 0001209191-24-000807 8561
2023-12-20 8-K 8-K 5.02,9.01 0001193125-23-299942 001-39536 231501541 34 452622 1 1
2023-12-20 S-8 S-8 0001193125-23-299939 333-276161 231501526 33 307092
2023-12-18 4 FORM 4 SUBMISSION 0001209191-23-058977 5815
2023-12-18 4 FORM 4 SUBMISSION 0001209191-23-058973 5887
2023-12-18 4 FORM 4 SUBMISSION 0001209191-23-058971 5863
2023-11-20 4 FORM 4 SUBMISSION 0001209191-23-055942 8588
2023-11-15 8-K 8-K 5.03,5.07,9.01 0001193125-23-277914 001-39536 231410967 34 165888 1 1
2023-11-14 8-K 8-K 2.02,9.01 0001193125-23-277165 001-39536 231407425 34 253536 1 1
2023-11-14 10-Q 10-Q 0000950170-23-063734 001-39536 231406595 34 13490758 1 1
2023-11-03 4 FORM 4 SUBMISSION 0001209191-23-054339 5485
2023-11-03 3 FORM 3 SUBMISSION 0001209191-23-054336 6620
2023-11-01 8-K 8-K 5.02 0001193125-23-268173 001-39536 231368114 34 155103 1 1
2023-10-05 DEF 14A DEF 14A 0001193125-23-251065 001-39536 231309796 34 231799
2023-09-26 8-K 8-K 7.01,9.01 0001193125-23-241943 001-39536 231277198 34 169555 1 1
2023-09-21 PRE 14A PRE 14A 0001193125-23-239550 001-39536 231269136 34 231916
2023-09-19 8-K 8-K 8.01,9.01 0001193125-23-237632 001-39536 231263803 34 166626 1 1
2023-09-11 424B3 424B3 0001193125-23-232444 333-274264 231247725 33 252481
2023-09-11 SC 13G/A filing.txt 0000315066-23-002575 005-91724 231246766 34 8207
2023-09-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-09-08 16:00:00 9999999995-23-002613 333-274264 231246562 33 1747
2023-09-07 CORRESP filename1.htm 0001193125-23-230112 7020
2023-09-06 UPLOAD filename1.pdf 0000000000-23-009862 40287
2023-08-30 S-3 S-3 0001193125-23-224918 333-274264 231225245 33 343544
2023-08-29 8-K 8-K 8.01 0001193125-23-222964 001-39536 231218029 34 147425 1 1
2023-08-28 SC 13G SC 13G 0001104659-23-096003 005-91724 231215723 34 192712
2023-08-25 SC 13G SC 13G 0001104659-23-095393 005-91724 231209154 34 88335
2023-08-25 4 FORM 4 SUBMISSION 0001209191-23-047323 5498
2023-08-25 D xslFormDX01/primary_doc.xml 06b 0001231919-23-000063 021-490724 231208733 33 13244
2023-08-25 SC 13G SC 13G 0001193125-23-221528 005-91724 231208635 34 76616
2023-08-24 144 xsl144X01/primary_doc.xml 0001968582-23-000435 001-39536 231203133 33 4343
2023-08-24 8-K 8-K 8.01,9.01 0001193125-23-219580 001-39536 231198943 34 177068 1 1
2023-08-21 SC 13D/A SC 13D/A 0001193125-23-216942 005-91724 231189098 34 117466
2023-08-18 SC 13D/A SC 13D/A 0001193125-23-216053 005-91724 231186706 34 115777
2023-08-16 4 FORM 4 SUBMISSION 0001209191-23-046154 8370
2023-08-16 4 FORM 4 SUBMISSION 0001209191-23-046152 8083
2023-08-16 4 FORM 4 SUBMISSION 0001209191-23-046150 5595
2023-08-16 4 FORM 4 SUBMISSION 0001209191-23-046148 4668
2023-08-14 10-Q 10-Q 0000950170-23-042089 001-39536 231166534 34 30355987 1 1
2023-08-14 8-K 8-K 1.01,2.02,3.02,8.01,9.01 0001193125-23-211456 001-39536 231166256 34 662023 1 1
2023-08-04 8-K 8-K 3.01 0001193125-23-203836 001-39536 231143931 34 152993 1 1
2023-07-31 8-K 8-K 7.01,9.01 0001193125-23-198580 001-39536 231125089 34 168748 1 1
2023-07-14 4 4 0000950170-23-032986 7878
2023-06-28 8-K 8-K 7.01,9.01 0001193125-23-176864 001-39536 231049347 34 187888 1 1
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039733 5459
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039732 5435
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039731 5542
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039730 5541
2023-06-26 3 FORM 3 SUBMISSION 0001209191-23-039728 8295
2023-06-26 4 FORM 4 SUBMISSION 0000899243-23-016491 8777
2023-06-23 8-K 8-K 5.07 0001193125-23-173983 001-39536 231038790 34 159328 1 1
2023-06-22 8-K 8-K 5.02 0001193125-23-172678 001-39536 231034155 34 157139 1 1
2023-06-22 4 FORM 4 SUBMISSION 0000899243-23-016232 8776
2023-06-20 144/A xsl144X01/primary_doc.xml 0001968582-23-000266 001-39536 231027007 33 4461
2023-06-20 144 xsl144X01/primary_doc.xml 0001968582-23-000263 001-39536 231025958 33 4313
2023-06-06 8-K 8-K 5.02 0001193125-23-161593 001-39536 23996048 34 154996 1 1
2023-06-05 8-K 8-K 8.01,9.01 0001193125-23-160348 001-39536 23991297 34 172563 1 1
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033681 5216
2023-06-01 144 xsl144X01/primary_doc.xml 0001231919-23-000039 001-39536 23986577 33 4625
2023-06-01 144 xsl144X01/primary_doc.xml 0001231919-23-000038 001-39536 23986574 33 4618
2023-05-19 8-K 8-K 8.01,9.01 0001193125-23-148827 001-39536 23937959 34 174956 1 1
2023-05-18 4 FORM 4 SUBMISSION 0001209191-23-030661 5175
2023-05-15 8-K 8-K 2.02,9.01 0001193125-23-145197 001-39536 23924269 34 234135 1 1
2023-05-11 144 xsl144X01/primary_doc.xml 0001231919-23-000029 001-39536 23912596 33 4230
2023-05-11 10-Q 10-Q 0000950170-23-021333 001-39536 23911718 34 26880791 1 1
2023-05-08 ARS ARS 0001193125-23-138235 001-39536 23897750 34 3811680
2023-05-08 DEFA14A DEFA14A 0001193125-23-138223 001-39536 23897680 34 1110109
2023-05-08 DEF 14A DEF 14A 0001193125-23-138221 001-39536 23897605 34 1020120
2023-05-04 424B3 424B3 0001193125-23-135884 333-271144 23888491 33 357579
2023-05-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-01 16:00:00 9999999995-23-001202 333-271144 23876470 33 1746
2023-04-27 CORRESP filename1.htm 0001193125-23-122153 15072
2023-04-27 8-K 8-K 3.01,5.02 0001193125-23-122129 001-39536 23856842 34 160219 1 1
2023-04-27 PRE 14A PRE 14A 0001193125-23-122098 001-39536 23856718 34 1019589
2023-04-27 10-K/A 10-K/A 0001193125-23-122086 001-39536 23856638 34 564545 1 1
2023-04-07 UPLOAD filename1.pdf 0000000000-23-003495 40265
2023-04-05 S-3 S-3 0001193125-23-092350 333-271144 23803078 33 732272
2023-03-29 424B5 424B5 0001193125-23-082441 333-260069 23771314 33 58684
2023-03-28 S-8 S-8 0001193125-23-082355 333-270915 23770794 33 77336
2023-03-28 10-K 10-K 0000950170-23-010343 001-39536 23770333 34 31433198 1 1
2023-03-28 8-K 8-K 2.02,9.01 0001193125-23-082174 001-39536 23769695 34 239354 1 1
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017342 9976
2023-03-08 8-K/A 8-K/A 5.02 0001193125-23-064669 001-39536 23717006 34 160934 1 1
2023-02-09 SC 13G/A filing.txt 0000315066-23-002096 005-91724 23605129 34 8016
2023-02-06 4 FORM 4 SUBMISSION 0001209191-23-007396 10637
2023-01-31 8-K 8-K 8.01,9.01 0001193125-23-020343 001-39536 23572642 34 182217 1 1
2023-01-19 8-K 8-K 5.02 0001193125-23-010947 001-39536 23537440 34 148234 1 1
2023-01-06 8-K/A 8-K/A 5.02 0001193125-23-003537 001-39536 23515135 34 169952 1 1
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001020 5571
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001019 5592
2022-12-23 4 FORM 4 SUBMISSION 0001209191-22-062615 5796
2022-12-22 8-K 8-K 5.02,8.01,9.01 0001193125-22-311027 001-39536 221482047 34 174524 1 1
2022-11-10 SC 13G/A filing.txt 0000315066-22-001829 005-91724 221375952 34 7833
2022-11-08 10-Q 10-Q 0001564590-22-036936 001-39536 221367430 34 26313248 1 1
2022-11-08 8-K 8-K 2.02,9.01 0001193125-22-279648 001-39536 221367183 34 239114 1 1
2022-11-07 D xslFormDX01/primary_doc.xml 06b 0001806310-22-000001 021-463996 221363884 33 12566
2022-11-02 4 FORM 4 SUBMISSION 0001209191-22-055263 7789
2022-11-02 SC 13D/A SC 13D/A 0001193125-22-275814 005-91724 221353915 34 96252
2022-10-31 3 FORM 3 SUBMISSION 0000899243-22-034545 13732
2022-10-31 SC 13D SC 13D 0001193125-22-273891 005-91724 221345960 34 172515
2022-10-31 8-K/A 8-K/A 1.01,3.02,8.01,9.01 0001193125-22-273298 001-39536 221343899 34 584036 1 1
2022-10-27 8-K 8-K 1.01,8.01,9.01 0001193125-22-271108 001-39536 221338228 34 433314 1 1
2022-10-27 424B5 424B5 0001193125-22-271102 333-260069 221338173 33 811896
2022-10-25 8-K 8-K 2.02,8.01,9.01 0001193125-22-268414 001-39536 221329928 34 189092 1 1
2022-10-25 424B5 424B5 0001193125-22-268409 333-260069 221329903 33 816245
2022-10-25 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-22-267999 001-39536 221327218 34 228621 1 1
2022-09-09 8-K 8-K 7.01 0001193125-22-242049 001-39536 221236698 34 147785 1 1
2022-08-24 4 FORM 4 SUBMISSION 0001209191-22-047353 5501
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-047097 9113
2022-08-11 10-Q 10-Q 0001564590-22-029155 001-39536 221157038 34 26092185 1 1
2022-08-11 8-K 8-K 2.02,9.01 0001193125-22-217962 001-39536 221153673 34 242354 1 1
2022-07-08 SC 13G us8776191061_070822.txt 0000834237-22-010356 005-91724 221075105 34 12324
2022-07-07 4 FORM 4 SUBMISSION 0001209191-22-041455 7386
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040356 9192
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038692 5426
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038691 5509
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038690 5411
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038689 5393
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038687 5402
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038685 5376
2022-06-21 8-K 8-K 5.07 0001193125-22-177619 001-39536 221028092 34 154114 1 1
2022-05-16 10-Q 10-Q 0001564590-22-020260 001-39536 22925736 34 28666099 1 1
2022-05-16 8-K 8-K 2.02,9.01 0001193125-22-150847 001-39536 22925390 34 252182 1 1
2022-04-28 DEFA14A DEFA14A 0001193125-22-127848 001-39536 22867675 34 171537
2022-04-28 DEF 14A DEF 14A 0001193125-22-127828 001-39536 22867609 34 772209
2022-04-08 4 FORM 4 SUBMISSION 0001209191-22-023863 5522
2022-04-08 4 FORM 4 SUBMISSION 0001209191-22-023862 5596
2022-03-31 424B5 424B5 0001193125-22-091855 333-260069 22792973 33 12249
2022-03-31 S-8 S-8 0001193125-22-091836 333-264025 22792915 33 82991
2022-03-31 10-K 10-K - UPDATED 0001564590-22-012782 001-39536 22789418 34 36146061 1 1
2022-03-31 8-K 8-K 2.02,9.01 0001193125-22-090671 001-39536 22789112 34 269826 1 1
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013163 5600
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013160 5526
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013156 5585
2022-02-09 SC 13G/A filing.txt 0000315066-22-001227 005-91724 22604651 34 8435
2022-02-07 SC 13G/A us8776191061_020722.txt 0000834237-22-007855 005-91724 22598015 34 13402
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007126 13760
2022-02-03 4 FORM 4 SUBMISSION 0001209191-22-006652 4535
2022-02-03 4 FORM 4 SUBMISSION 0001209191-22-006641 4631
2022-01-31 8-K 8-K 8.01,9.01 0001193125-22-022338 001-39536 22571296 34 191699 1 1
2022-01-27 8-K 8-K 8.01,9.01 0001193125-22-019000 001-39536 22559879 34 184315 1 1
2021-12-08 4 FORM 4 SUBMISSION 0001209191-21-068510 8629
2021-11-29 4 FORM 4 SUBMISSION 0001209191-21-067005 7200
2021-11-24 4 FORM 4 SUBMISSION 0001209191-21-066702 7200
2021-11-10 10-Q 10-Q 0001564590-21-056225 001-39536 211397101 34 22742099 1 1
2021-11-10 8-K 8-K 2.02,9.01 0001193125-21-325269 001-39536 211394402 34 281806 1 1
2021-10-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-10-14 16:00:00 9999999995-21-003891 333-260069 211324687 33 1747
2021-10-12 CORRESP filename1.htm 0001193125-21-296887 8086
2021-10-12 UPLOAD filename1.pdf 0000000000-21-012325 40224
2021-10-05 S-3 S-3 0001193125-21-292221 333-260069 211307568 33 1532751
2021-10-05 8-K 8-K 8.01,9.01 0001193125-21-291535 001-39536 211305139 34 175646 1 1
2021-09-24 SC 13G taysha13ga.htm 0001019231-21-000010 005-91724 211273528 34 9632
2021-08-20 4 FORM 4 SUBMISSION 0001209191-21-052824 12734
2021-08-16 10-Q 10-Q 0001564590-21-044462 001-39536 211174762 34 10899476 1 1
2021-08-16 8-K 8-K 2.02,7.01,9.01 0001193125-21-246904 001-39536 211174482 34 291885 1 1
2021-07-01 4 FORM 4 SUBMISSION 0001209191-21-044563 16409
2021-06-29 8-K 8-K 7.01,9.01 0001193125-21-202639 001-39536 211055721 34 26806207
2021-06-28 8-K FORM 8-K 7.01,9.01 0001193125-21-201075 001-39536 211049965 34 36980288
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042112 5487
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042110 5389
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042107 5371
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042106 5380
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042101 5404
2021-06-21 4 FORM 4 SUBMISSION 0001209191-21-042087 5354
2021-06-17 8-K 8-K 5.07 0001193125-21-193328 001-39536 211025703 34 21399
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035165 6029
2021-05-17 4 FORM 4 SUBMISSION 0001209191-21-033009 7200
2021-05-11 S-8 S-8 0001193125-21-157741 333-256013 21912387 33 62836
2021-05-11 10-Q 10-Q 0001564590-21-026559 001-39536 21911528 34 5870177 1
2021-05-11 8-K 8-K 2.02,9.01 0001193125-21-156965 001-39536 21909596 34 106112
2021-04-29 DEF 14A DEF 14A 0001193125-21-140758 001-39536 21871826 34 720950
2021-04-14 8-K 8-K 7.01,8.01,9.01 0001193125-21-116308 001-39536 21825925 34 24385037
2021-04-12 8-K 8-K 8.01,9.01 0001193125-21-112434 001-39536 21819354 34 45542
2021-03-09 8-K 8-K 8.01,9.01 0001193125-21-073904 001-39536 21724096 34 34762
2021-03-05 8-K/A 8-K/A 2.02,9.01 0001193125-21-071533 001-39536 21718879 34 74071
2021-03-03 10-K 10-K 0001564590-21-010433 001-39536 21707362 34 10472968 1
2021-03-03 8-K 8-K 2.02,9.01 0001193125-21-066597 001-39536 21707218 34 86919
2021-02-16 5 FORM 5 SUBMISSION 0001209191-21-010878 6127
2021-02-16 SC 13G taysha13g.htm 0001019231-21-000007 005-91724 21635711 34 9419
2021-02-12 8-K 8-K 8.01,9.01 0001193125-21-041656 001-39536 21628097 34 42074
2021-02-08 SC 13G/A filing.txt 0000315066-21-001299 005-91724 21599841 34 8387
2021-02-02 SC 13G us8776191061_020221.txt 0000834237-21-007057 005-91724 21580776 34 13150
2021-02-01 8-K 8-K 8.01,9.01 0001193125-21-023671 001-39536 21574332 34 56339
2021-01-20 4 FORM 4 SUBMISSION 0001209191-21-004573 5495
2021-01-20 4 FORM 4 SUBMISSION 0001209191-21-004572 5512
2021-01-20 4 FORM 4 SUBMISSION 0001209191-21-004571 5438
2021-01-19 8-K 8-K 8.01,9.01 0001193125-21-010793 001-39536 21533916 34 41227
2021-01-15 8-K 8-K 1.01,2.03 0001193125-21-010133 001-39536 21532510 34 20225
2020-12-21 8-K 8-K 8.01,9.01 0001193125-20-322291 001-39536 201402372 34 43559
2020-12-17 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-20-320071 001-39536 201396296 34 51403
2020-12-03 8-K 8-K 8.01,9.01 0001193125-20-308933 001-39536 201365686 34 36195
2020-11-24 4 FORM 4 SUBMISSION 0001209191-20-060227 5313
2020-11-24 4 FORM 4 SUBMISSION 0001209191-20-060225 5289
2020-11-24 3 FORM 3 SUBMISSION 0001209191-20-060222 6601
2020-11-24 3 FORM 3 SUBMISSION 0001209191-20-060221 6560
2020-11-24 8-K 8-K 5.02,7.01,9.01 0001193125-20-301981 001-39536 201339880 34 35773
2020-11-12 10-Q 10-Q 0001564590-20-053602 001-39536 201307140 34 5445692 1
2020-11-12 8-K 8-K 2.01,9.01 0001193125-20-291719 001-39536 201307119 34 71289
2020-11-05 8-K 8-K 8.01,9.01 0001193125-20-286290 001-39536 201288831 34 30075
2020-11-04 8-K 8-K 1.01 0001193125-20-285213 001-39536 201285356 34 20254
2020-10-27 8-K 8-K 8.01,9.01 0001193125-20-277634 001-39536 201262146 34 29375
2020-10-14 8-K 8-K 8.01,9.01 0001193125-20-269048 001-39536 201238294 34 37147
2020-10-13 SC 13G filing.txt 0000315066-20-001803 005-91724 201235153 34 8381
2020-10-07 8-K 8-K 8.01,9.01 0001193125-20-265562 001-39536 201229213 34 38776
2020-10-05 SC 13D ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-20-008773 005-91724 201224588 34 88089
2020-10-05 SC 13D ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-20-008761 005-91724 201224268 34 75296
2020-09-30 4 FORM 4 SUBMISSION 0001209191-20-052463 7019
2020-09-30 4 FORM 4 SUBMISSION 0001209191-20-052462 11544
2020-09-30 4 FORM 4 SUBMISSION 0001209191-20-052460 6946
2020-09-30 4 FORM 4 SUBMISSION 0001209191-20-052459 15878
2020-09-29 8-K 8-K 5.03,9.01 0001193125-20-257858 001-39536 201209270 34 48844
2020-09-29 S-8 S-8 0001193125-20-257854 333-249130 201209249 33 87359
2020-09-25 4 FORM 4 SUBMISSION 0001209191-20-052116 4966
2020-09-25 4 FORM 4 SUBMISSION 0001209191-20-052115 5282
2020-09-25 4 FORM 4 SUBMISSION 0001209191-20-052114 5300
2020-09-25 4 FORM 4 SUBMISSION 0001209191-20-052113 5265
2020-09-25 4 FORM 4 SUBMISSION 0001209191-20-052112 5398
2020-09-25 4 FORM 4 SUBMISSION 0001209191-20-052110 4901
2020-09-25 424B4 424B4 0001193125-20-253550 333-248559 201196204 33 4871479
2020-09-23 SEC STAFF LETTER filename1.pdf 9999999997-20-004757 275521
2020-09-23 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-09-23 16:00:00 9999999995-20-002541 333-248559 201193428 33 1687
2020-09-23 3 FORM 3 SUBMISSION 0001209191-20-051744 8941
2020-09-23 3 FORM 3 SUBMISSION 0001209191-20-051743 8015
2020-09-23 3 FORM 3 SUBMISSION 0001209191-20-051742 9510
2020-09-23 3 FORM 3 SUBMISSION 0001209191-20-051741 9204
2020-09-23 3 FORM 3 SUBMISSION 0001209191-20-051740 10938
2020-09-23 3 FORM 3 SUBMISSION 0001209191-20-051739 7958
2020-09-23 3 FORM 3 SUBMISSION 0001209191-20-051738 6536
2020-09-23 S-1MEF S-1MEF 0001193125-20-252504 333-249001 201193037 33 53161
2020-09-23 CERT 8A_Cert_TSHA2.pdf 0001354457-20-000511 001-39536 201190436 34 86300
2020-09-21 CORRESP filename1.htm 0001193125-20-250161 10009
2020-09-21 CORRESP filename1.htm 0001193125-20-250155 13467
2020-09-18 8-A12B 8-A12B 0001193125-20-249136 001-39536 201184264 34 14769
2020-09-18 S-1/A S-1/A 0001193125-20-248359 333-248559 201182633 33 5144659
2020-09-17 CORRESP filename1.htm 0001193125-20-247569 25294
2020-09-17 S-1/A S-1/A 0001193125-20-247565 333-248559 201180062 33 6184894
2020-09-16 UPLOAD filename1.pdf 0000000000-20-008748 47956
2020-09-11 SEC STAFF LETTER filename1.pdf 9999999997-20-004642 228449
2020-09-08 CORRESP filename1.htm 0001193125-20-241070 39635
2020-09-08 S-1/A S-1/A 0001193125-20-241062 333-248559 201164579 33 4970400
2020-09-02 S-1 S-1 0001193125-20-238197 333-248559 201157511 33 6651742

Latest XBRL company facts

One latest value per concept from companyfacts (247 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 326.05M 2026-11-12 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
dei EntityPublicFloat Entity Public Float USD 544.80M 2025-06-30 2025 FY 10-K 2026-03-19 0001193125-26-115202
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 9.42M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-168525
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.12M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-168525
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 18.26M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-168525
ecd PeoTotalCompAmt PeoTotalCompAmt USD 4.10M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-168525
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 310.73 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-168525
ffd NetFeeAmt NetFeeAmt USD 31,763 2026-06-25 424B5 2026-06-25 0001193125-26-282846
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 230.00M 2026-06-25 424B5 2026-06-25 0001193125-26-282846
ffd TtlFeeAmt TtlFeeAmt USD 31,763 2026-06-25 424B5 2026-06-25 0001193125-26-282846
ffd TtlOfferingAmt TtlOfferingAmt USD 230.00M 2026-06-25 424B5 2026-06-25 0001193125-26-282846
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-06-25 424B5 2026-06-25 0001193125-26-282846
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-06-25 424B5 2026-06-25 0001193125-26-282846
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 17.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.73M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053602
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 5.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 2.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.19B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 17.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 15.14M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012782
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 17.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 39.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 4.80M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap Assets Assets USD 435.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AssetsCurrent Assets, Current USD 426.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 420.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 2.00M 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 25,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 26.25M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap Cash Cash USD 197.40M 2021-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044462
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 422.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 188.80M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056225
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 423.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 100.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 317.10M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 700.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 325.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 325.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap CommonStockValue Common Stock, Value, Issued USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -125.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 1.10M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126416
us-gaap CumulativeEarningsDeficit Cumulative Earnings (Deficit) USD 200,000 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033484
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.07 2021-08-12 2024 Q2 10-Q 2024-08-12 0000950170-24-095082
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 1.45M 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063734
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 3.00M 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap DeferredCostsLeasingNetNoncurrent Deferred Costs, Leasing, Net, Noncurrent USD 630,000 2022-09-30 2022 Q3 10-Q 2022-11-08 0001564590-22-036936
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 110,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap DeferredRevenue Deferred Revenue USD 28.90M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021333
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 9.77M 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.95M 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063734
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 4.96M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 140.41M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 34.17M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 69.45M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 13.85M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 27.10M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 5.77M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 65,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.94M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 137.72M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 2.68M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.06M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 619,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2024-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap Depreciation Depreciation USD 843,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 140.53M 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063734
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 60,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053602
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.31 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001564590-22-020260
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.231 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.059 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.023 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.15 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.061 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 463,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 57,000 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-263506
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 58,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 399,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 73,000 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 73,000 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033484
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 325,000 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033484
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 399,000 2024-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 58,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.109 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD -4.80M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 3.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -1.40M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 34.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 25.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -22.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 6.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.58M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053602
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -4.29M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -8,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 604,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053602
us-gaap InterestExpense Interest Expense USD 56,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095082
us-gaap InterestExpenseLongTermDebt Interest Expense, Long-term Debt USD 4.90M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 3.13M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095082
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 4.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 8.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 49.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LeaseCost Lease, Cost USD 2.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 9.44M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 11.40M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.52M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 493,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap Liabilities Liabilities USD 78.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 435.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LiabilitiesCurrent Liabilities, Current USD 22.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 49.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LongTermDebt Long-term Debt USD 38.35M 2023-06-30 2023 Q2 10-Q 2023-08-14 0000950170-23-042089
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 6.67M 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063734
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 38.03M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 38.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 11.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 20.00M 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063734
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 47.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 218.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -3.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -114.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -128.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -128.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 606,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 4.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingExpenses Operating Expenses USD 132.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -132.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001564590-22-036936
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 7.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 796,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 52.15M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 4.20M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 3.87M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 4.37M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 4.30M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 30.56M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 4.85M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010343
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.107 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 217.90M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 515,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OtherAssetsCurrent Other Assets, Current USD 659,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 48,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.49M 2021-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012782
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -155,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 8,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021333
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -187,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD -131,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 18,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 387,000 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095082
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 466,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 604,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053602
us-gaap PrepaidInsurance Prepaid Insurance USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 165.85M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012782
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 500,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 18.60M 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044462
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 225,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -166,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 1.67M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012782
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 2.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 463,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -128.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 7.66M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits Property Subject to or Available for Operating Lease, Number of Units sqft 187,500 2020-12-17 2020 FY 10-K 2021-03-03 0001564590-21-010433
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 1.67M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012782
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 101.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 3.50M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0000950170-23-042089
us-gaap RestrictedCash Restricted Cash USD 165,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 449,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 165,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.35 2022-01-01 2022-03-31 2022 Q2 10-Q 2022-08-11 0001564590-22-029155
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -839.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap Revenues Revenues USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 23.43M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033484
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 159,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 11.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount Settlement of Asset Retirement Obligations Through Noncash Payments, Amount USD 449,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027348
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 17.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date pure 0.15 2022-02-01 2022-02-28 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate pure 0.85 2022-02-28 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee shares 1,800 2022-02-01 2022-02-28 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 3.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 7.52 2020-06-30 2021 FY 10-K 2022-03-31 0001564590-22-012782
us-gaap SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 356.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap StockIssued1 Stock Issued USD 177,000 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044462
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 142.24M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012782
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 463,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 11.61M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063734
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 2.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 15.65M 2020-07-28 2021 FY 10-K 2022-03-31 0001564590-22-012782
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2019-12-31 2020 FY 10-K 2021-03-03 0001564590-21-010433
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 7.80M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033484
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 400,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033484
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 23.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap VariableLeaseCost Variable Lease, Cost USD 595,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115202
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 380.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 38.17M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001564590-22-020260
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 380.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456949

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →